Recombinant Proteins

p53
LBP
CEA
HLA
TCL
TTC
NPM
MAF
Bax
BID

MYL9 Mouse

Myosin Light Chain 9 Mouse Recombinant

Recombinant MYL9 Mouse, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 196 amino acids (1-172 a.a) and has a molecular mass of 22.4 kDa. The protein includes a 24 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT15997
Source
Escherichia Coli.
Appearance
The product is a clear, sterile-filtered solution.

MYLPF Human

Myosin Light chain, Phosphorylatable, Fast Skeletal Muscle Human Recombinant

The MYLPF protein offered here is produced in E. coli and is a single, non-glycosylated polypeptide chain. It consists of 189 amino acids, including a 20 amino acid His-tag at the N-terminus, and has a molecular weight of 21.2 kDa. The protein is purified using proprietary chromatographic techniques to ensure high purity.
Shipped with Ice Packs
Cat. No.
BT16068
Source
Escherichia Coli.
Appearance
The MYLPF protein solution is sterile filtered and colorless.

MYL5 (1-173 a.a.) Human

Myosin Light Chain 5 (1-173 a.a.) Human Recombinant

This product consists of the human recombinant MYL5 protein, specifically amino acids 1 to 173, produced in E. coli bacteria. It is a single, non-glycosylated polypeptide chain with a molecular weight of 22.1 kDa. A 24-amino acid His-tag is attached to the N-terminus for purification purposes. The protein has been purified using proprietary chromatographic techniques to ensure high purity.
Shipped with Ice Packs
Cat. No.
BT15543
Source
Escherichia Coli.
Appearance
Clear, colorless solution that has been sterilized by filtration.

MYL5 Human

Myosin Light Chain 5 Human Recombinant

Recombinant human MYL5, produced in E. coli, is a single, non-glycosylated polypeptide chain containing 156 amino acids (1-132 a.a.) with a molecular mass of 17.4 kDa. It is fused to a 24 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT15604
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.

NMM Human

Non-Muscle Myosin-II Regulatory Light Chain Human Recombinant

This product consists of the full-length recombinant human Non-Muscle Myosin-II Regulatory Light Chain, expressed in E. coli and purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT16169
Source
Escherichia Coli.
Appearance
Clear, sterile-filtered solution.
Definition and Classification

Myosin light chains (MLCs) are small polypeptide subunits of myosin, a motor protein involved in muscle contraction and various cellular processes. MLCs are classified into two main types: Essential or Alkali MLCs (MLC1 or ELC) and Regulatory MLCs (MLC2 or RLC) . Essential MLCs are crucial for the structural integrity of the myosin molecule, while regulatory MLCs play a role in modulating the activity of myosin through phosphorylation .

Biological Properties

Key Biological Properties: MLCs belong to the EF-hand family of Ca²⁺-binding proteins and contain two Ca²⁺-binding EF-hand motifs . They are involved in force transduction and cross-bridge kinetics in muscle contraction .

Expression Patterns and Tissue Distribution: MLCs are expressed in various tissues, including striated muscle (skeletal and cardiac) and smooth muscle . Specific genes encode different MLC isoforms, such as MYL1, MYL3, MYL4, and MYL6 for MLC1, and MYL2, MYL5, MYL7, and MYL9 for MLC2 .

Biological Functions

Primary Biological Functions: MLCs are essential for muscle contraction by stabilizing the myosin head and modulating its interaction with actin . They contribute to force production and the regulation of muscle contraction dynamics .

Role in Immune Responses and Pathogen Recognition: While MLCs are primarily known for their role in muscle contraction, they also play a part in cellular motility and immune responses by facilitating the movement of immune cells .

Modes of Action

Mechanisms with Other Molecules and Cells: MLCs interact with the neck region of myosin heavy chains (MHCs), stabilizing the complex and enabling the motor protein’s function . Regulatory MLCs undergo phosphorylation, which induces conformational changes that modulate myosin activity .

Binding Partners and Downstream Signaling Cascades: MLCs bind to actin filaments and are involved in the ATP-dependent cyclic interactions that drive muscle contraction . The phosphorylation of regulatory MLCs by myosin light chain kinase (MLCK) is a key regulatory step .

Regulatory Mechanisms

Transcriptional Regulation: The expression of MLC genes is regulated by various transcription factors and signaling pathways that respond to developmental and physiological cues .

Post-Translational Modifications: Phosphorylation is the primary post-translational modification that regulates MLC activity. MLCK phosphorylates regulatory MLCs, enhancing their interaction with actin and promoting muscle contraction .

Applications

Biomedical Research: MLCs are studied extensively in muscle physiology and pathology, providing insights into muscle function and diseases .

Diagnostic Tools: Alterations in MLC expression or function can serve as biomarkers for muscle-related diseases, such as cardiomyopathies .

Therapeutic Strategies: Targeting MLC phosphorylation pathways holds potential for developing treatments for muscle disorders and improving muscle function .

Role in the Life Cycle

Development: MLCs are crucial for muscle development and differentiation, with specific isoforms expressed at different developmental stages .

Aging and Disease: Changes in MLC expression and function are associated with age-related muscle decline and various muscle diseases, including hypertrophic and dilated cardiomyopathy .

© Copyright 2024 Thebiotek. All Rights Reserved.